Rx Rundown: Sanofi, Novartis, Roche and more
Deals: Novo Holdings’ $16.5 billion acquisition of Catalent is on track to close. Merck signed a deal worth up to $2 billion with Hansoh Pharma to develop and sell the Chinese biotech’s experimental oral GLP-1 drug. BioAge Labs secured a multiyear …